$12 Million in New Funding closed by MedVentive, a Long River Ventures portfolio company

Provider-based Funds Support Company Growth, Continued ACO Innovation

October 27, 2011 - AMHERST, MA: Long River Ventures announced today that its portfolio company MedVentive completed a $12 million Series D investment, led by the investment arms of two of the country's largest healthcare provider networks, National Healthcare Services (NHS) and CHV II, LP. Both new investors are focused on transformative technology for the healthcare market. They were joined by MedVentive's existing investors: Long River Ventures, Clarian Health Ventures, Core Capital Partners, Excel Venture Management, and HLM Venture Partners. Including Clarian Health Ventures, MedVentive now has the backing of three of the nation's most prestigious hospital investors. The investment validates MedVentive's accelerating innovation and strong company position as the leading provider of population and risk management solutions for health plans and providers.

"We have been evaluating organizations in the Accountable Care Organization (ACO) space extensively," said Brant Heise, representative of NHS. "Through rigorous market analysis, we determined that MedVentive is uniquely positioned in the healthcare field for its ability to support health plans and providers and focus on population and provider-centered risk management. It is evident that MedVentive's tools can greatly help our provider organizations achieve core business goals."

NHS is the investment arm of MemorialCare Health System in California. MemorialCare has been recognized as one of the nation's most innovative health systems by such organizations as Thomson Reuters and The Governance Institute. CHV II is a strategic venture fund investing on behalf of four of the largest non-profit health systems in the country. The fund's objectives are to support strategic investments that have the potential to transform the healthcare industry, and significantly enhance the quality of patient care.

"We are delighted to welcome NHS and CHV II to the MedVentive investment syndicate," commented Nancy J. Ham, MedVentive President and CEO. Both are exceptional provider-based investors with an emphasis on bringing tools to market that will support the delivery of cost effective and efficient care," she added. "Their investment is a true vote of confidence in MedVentive's growth and success."

Will Cowen, Managing Partner of Long River Ventures, one of the earliest investors in MedVentive, added, "This is an exceptional management team with industry leading ACO solutions. Since our initial investment we're been working with the team to bring in additional investors with deep domain expertise. We are thrilled to have three of the country's leading health system investors as part of the investor syndicate."

MedVentive is extremely well positioned to meet the market needs for clinical integration, population management and management of financial risk for achieving stated quality and utilization goals. For more than a decade, MedVentive has been helping leading healthcare organizations support clinical integration initiatives and successfully manage their quality, utilization, pharmacy, and physician incentive programs. Its clients have achieved significant results using the MedVentive suite of Web-based applications to engage physicians and to optimize quality performance at the patient and population levels.

About MedVentive
For more than a decade, MedVentive has worked with leading provider and health plan organizations to develop and deploy innovative, clinically sophisticated approaches to successfully reduce healthcare costs and improve the quality of patient care. MedVentive offers a fully-integrated suite of business & clinical intelligence and outreach applications that support best-in-class pay for performance programs, physician efficiency profiling and information-sharing, quality intervention, pharmacy management, and point-of-care decision support tools – all built on a risk-adjusted data foundation. Provider groups and health plans use MedVentive technology and services to identify their greatest healthcare improvement opportunities and to act quickly and efficiently to effect change through flexible, tailored solutions.

For more information, visit www.medventive.com.

About National Healthcare Services
National Healthcare Services (NHS) is a strategic investment company wholly owned by the MemorialCare Health System in California. The goal of NHS is to invest in companies that provide innovative products, services and technology to hospitals and physicians that have the potential to enhance operating and clinical performance.

For more information, visit www.nationalhealthcareservices.com.

CHV II, LP
CHV II, LP, is a limited partnership that invests in healthcare technology, services and medical device sectors on behalf of four of the largest non-profit health systems in the country.

About Long River Ventures
Over the past 10 years, Long River Ventures has invested in seed and early stage companies in healthcare, IT, and other technology-driven sectors. Formed by a group of experienced entrepreneurs and venture capitalist, Long River Ventures is designed and structured to invest smaller amounts of capital with typical initial investments of $250,000 to $1MM. Long River Ventures is currently investing out of its third fund, is headquartered in Amherst, Massachusetts with offices in Worcester and Boston.

For more information, visit www.longriverventures.com.